Ligand validation:3GXF

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3GXF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3GXF_NAG_C_513	83%	28%	0.108	0.967	0.92	1.92	-	5	0	0	100%	0.9333
3GXF_NAG_A_516	75%	35%	0.126	0.959	0.93	1.63	-	5	0	0	100%	0.9333
3GXF_NAG_D_511	56%	31%	0.138	0.909	0.82	1.9	-	4	0	0	100%	0.9333
3GXF_NAG_B_516	51%	34%	0.143	0.896	0.7	1.87	-	6	2	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
3GXI_NAG_C_498	95%	42%	0.059	0.96	0.9	1.34	1	2	0	0	100%	0.9333
2NT1_NAG_D_498	83%	20%	0.095	0.953	0.75	2.57	-	5	2	0	100%	0.9333
3RIL_NAG_A_512	74%	12%	0.105	0.934	2.54	1.54	8	4	0	0	100%	0.9333
3GXM_NAG_D_498	73%	22%	0.101	0.927	0.58	2.6	-	4	0	1	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.